GenMark Diagnostics to Present at the Canaccord Genuity Medical Technology & Diagnostics Forum
CARLSBAD, Calif.--(BUSINESS WIRE)--GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, will present at the Canaccord Genuity Medical Technology & Diagnostics Forum to be held at the Le Parker Meridien in New York, NY on December 4, 2012.